EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 26 / No 3 (Mars 2010) Med Sci (Paris), 26 3 (2010) 281-290 References
Free Access
Issue
Med Sci (Paris)
Volume 26, Number 3, Mars 2010
Page(s) 281 - 290
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010263281
Published online 15 March 2010
  1. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18 : 1615–27. [Google Scholar]
  2. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine 2002; 81 : 213–27. [Google Scholar]
  3. French MA. Immune reconstitution inflammatory syndrome: a reapparaisal. Clin Infect Dis 2009; 48 : 101–7. [Google Scholar]
  4. Chen VCC, Yuen KY, Wong SSY, et al. Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 2001; 20 : 402–6. [Google Scholar]
  5. Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005; 40 : 1756–61. [Google Scholar]
  6. Micelli MH, Maertens J, Buvé K, et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia : proof of principle, description, and clinical and research implications. Cancer 2007; 110 : 112–20. [Google Scholar]
  7. Garcia-Vidal C, Rodriguez Fernandez S, Martinez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005; 40 : 756–9. [Google Scholar]
  8. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 2007; 45 : 1192–9. [Google Scholar]
  9. Breton G. Syndrome de reconstitution immunitaire chez les patients infectés par le VIH. La Lettre de l’Infectiologue 2006; 3 : 116–25. [Google Scholar]
  10. Meintjes G, Lawn S, Scanio F, et al. For the international network for the study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definition for use in resource-limited settings. Lancet Infect Dis 2008; 8 : 516–23. [Google Scholar]
  11. Haddow LJ, Moosa MY, Easterbrook PJ. Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24 : 103–8. [Google Scholar]
  12. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158 : 157–61. [Google Scholar]
  13. Breton G. Immune reconstitution inflammatory syndrome. In: Schaaf SH, Zumla A, eds. Tuberculosis: a comprehensive clinical reference. New York : Saunders-Elsevier, 2009; 689–700. [Google Scholar]
  14. Lortholary O, Fontanet A, Némain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 2005; 19 : 1043–9. [Google Scholar]
  15. Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006; 20 : 119–21. [Google Scholar]
  16. Legrand F, Lecuit M Dupont B, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008; 46 : 696–702. [Google Scholar]
  17. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006; 20 : F1–7. [Google Scholar]
  18. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lympadenitis and cryptococcal meningitis. HIV Med 2008; 9 : 307–16. [Google Scholar]
  19. Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 2005; 80 : 1131–3. [Google Scholar]
  20. Seddiki N, Sasson SC, Santaner-Nanan B, et al. Proliferation of weakly suppressive regulatory CD4 T cells is associated with over-active CD4 T cell response in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol 2009; 39 : 391–403. [Google Scholar]
  21. Bourgarit A, Carcelain G, Samri A, et al. TB-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4Th1 cells and can be predicted by KIR-negative gd T cells. Montreal : 16th Conference on retroviruses and opportunistic infections, 2009 (abstract 772). [Google Scholar]
  22. Price P, Morahan G, Huang D, et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002; 16 : 2043–7. [Google Scholar]
  23. Vendrely A, Bienvenu B, Gasnault J, et al. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005; 109 : 449–55. [Google Scholar]
  24. Egli A, Bergamin O, Müllhaupt B, et al. Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transpl Infect Dis 2008; 10 : 27–43. [Google Scholar]
  25. Bochud PY, Hawn TR, Siddiqui MR, et al. Toll-like receptor 2 polymorphisms are associated with reversal reaction in leprosy. J Infect Dis 2008; 197 : 253–61. [Google Scholar]
  26. Lawn SD, Myer L, Bekker LG, et al. Tuberculosis associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21 : 335–41. [Google Scholar]
  27. Manabe YC, Cambell JD, Sydnor E, et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007; 46 : 456–62. [Google Scholar]
  28. Murdoch DM, Venter WDF, Feldman C, Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in south Africa: a prospective study. AIDS 2008; 22 : 601–10. [Google Scholar]
  29. Cheng VCC, Yam WC, Woo PCY, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003; 22 : 597–602. [Google Scholar]
  30. Azoulay E, Darmon M, Delchaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30 : 781–6. [Google Scholar]
  31. Shelburne SA, Visnegarwala F, Darcourt, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during higly active antiretroviral therapy. AIDS 2005; 19 : 399–406. [Google Scholar]
  32. Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39 : 1709–12. [Google Scholar]
  33. Cinque P, Bossolasco S, Brambilla AM, et al. The effect of HAART-induced immune reconstitution on development and outcome of progressive multifocal encephalopathy : study of 43 cases with review of the litterature. J Neurovirol 2003; 9 : 73–80. [Google Scholar]
  34. Tan K, Roda R, Ostrow L, Mc Arthur J, Nath A. PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 2009; 72 : 1458–64. [Google Scholar]
  35. Cheng VCC, Ho PL, Lee RA, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21 : 803–9. [Google Scholar]
  36. Cheng VCC, Woo PCY, Lau SKP, et al. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microb Infect Dis 2003; 22 : 313–7. [Google Scholar]
  37. Park WB, Choe PG, Jo JH, et al. Immune reconstitution inflammatory syndrome in the first year after HAART: influence on long term outcome. AIDS 2006; 20 : 2390–2. [Google Scholar]
  38. Kaplan JE, Benson C, Homes KK, Brooks JT, Masur TT. Guidelines for prevention and treatment of opportunistics infections in HIV-infected adults and adolescents. Morb Mortal Wkly Rep (MMWR) 2009; 58 : 1–198. [Google Scholar]
  39. Meintjes G, Wilkinson R, Morroni C, et al. Randomiszed placebo-controlled trial of prednisone for the TB IRIS. Montreal : 16th Conference on retroviruses and opportunistic infections, 2009 (abstract 34). [Google Scholar]
  40. Zolopa A, Anderson J, Komarow L, et al. Immediate versus deferred ART in the setting of acute AIDS-related opportunistic infection: final results of a randomized strategy trial, ACTG 5164. Boston : 15th Conference on retroviruses and opportunistic infections, 2008 (abstract 142). [Google Scholar]
  41. Catros V, Bouet F, Cabillic F, et al. Lymphocytes T gamma delta en cancérologie : des lymphocytes tueurs non conventionnels. Med Sci (Paris) 2010; 26 : 185–93. [Google Scholar]
  42. Leung-Theung-Long S, Guerder S. Les cellules Th17 : une nouvelle population de cellules T CD4 effectrices pro-inflammatoires.Med Sci (Paris) 2008; 24 : 972–6. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.